期刊文献+

皮肤无细胞基质材料在乳房假体重建中的运用情况

Application of Acellular Dermal Matrix in Implant-Based Breast Reconstruction
原文传递
导出
摘要 目的了解皮肤无细胞基质材料在乳房假体重建中的应用情况及研究进展。方法查阅近年来有关皮肤无细胞基质材料在乳房假体重建中应用的相关文献并进行分析总结。结果皮肤无细胞基质材料广泛应用于乳房假体重建及乳房调整性手术,能精确控制乳房下皱襞及增强周围组织对假体的控制从而获得较好的重建效果,但是其是否会增加乳房假体重建术后的并发症发生率目前尚无统一的结论。结论皮肤无细胞基质材料辅助的假体重建能取得较为满意的重建效果,目前亟需大样本随机对照试验评估其运用的效果及风险。 Objective To understand the application of acellular dermal matrix(ADM) in implant-based breast reconstruction. Method Literatures on application of ADM in the implant-based breast reconstruction were reviewed. Results ADM was widely used in the implant-based breast reconstruction and revisionary breast surgery. ADM could help to achieve a better reconstruction outcome by precisely locating the inferior mammary fold and strengthening the local control of the implant. However, whether ADM might increase the postoperative complications was controversial. Conclusion ADM assisted implant-based breast reconstruction could achieve a better cosmetic outcome, but the large sample randomized controlled trial is needed to evaluate the application effect and risk of ADM.
作者 谭秋雯 吕青
出处 《中国普外基础与临床杂志》 CAS 2015年第8期1019-1022,共4页 Chinese Journal of Bases and Clinics In General Surgery
基金 成都市科技局-华西医院转化医学创新基金项目(编号:ZH13033)~~
关键词 无细胞基质材料 乳房重建 假体重建 Acellular dermal matrix Breast reconstruction Implant-based reconstruction
  • 相关文献

参考文献36

  • 1Servick K. Breast cancer: a world of differences. Science, 2014, 343 (6178): 1452-1453.
  • 2黄哲宙,陈万青,吴春晓,郑荣寿,陈建国,杨念念,王宁,张思维,郑莹.中国女性乳腺癌的发病和死亡现况——全国32个肿瘤登记点2003—2007年资料分析报告[J].肿瘤,2012,32(6):435-439. 被引量:369
  • 3Gandhi A, Barr L, Johnson R. Bioprosthetics: changing the landscape for breast reconstruction? Eur J Surg Oncol, 2013, 39(1): 24-25.
  • 4Jansen LA, Macadam SA. The use of AlloDerm in postmastectomy alloplastic breast reconstruction: part I. A systematic review. Plast Reconstr Surg, 2011, 127(6): 2232-2244.
  • 5Duncan DI. Correction of implant rippling using allograft dermis. Aesthet Surg J, 2001, 21(1): 81-84.
  • 6Jeevan R, Cromwell D, Browne J, et al. National mastectomy and breast reconstruction audit 2011. http://www.hscic.gov.uk/catalogue/PUB02731/clin-audi-supp-prog-mast-brea-reco-2011-rep1.pdf.
  • 7羊晓勤,李宏江.乳腺癌乳房切除术后假体重建[J].华西医学,2011,26(7):1006-1009. 被引量:3
  • 8Glasberg SB, Light D. AlloDerm and Strattice in breast reconstruction: a comparison and techniques for optimizing outcomes. Plast Reconstr Surg, 2012, 129(6): 1223-1233.
  • 9Winters ZE, Colwell AS. Role of acellular dermal matrix-assisted implants in breast reconstruction. Br J Surg, 2014, 101(5): 444-445.
  • 10Wallace MS, Wallace A M, Lee J, et al. Pain after breast surgery: a survey of 282 women. Pain, 1996, 66(2): 195-205.

二级参考文献38

  • 1杨玲,李连弟,陈育德,D.M.Parkin.中国乳腺癌发病死亡趋势的估计与预测[J].中华肿瘤杂志,2006,28(6):438-440. 被引量:278
  • 2全国肿瘤防治研究办公室,全国肿瘤登记中心,卫生部疾病预防控制局.中国肿瘤死亡报告-全国第三次死因回顾抽样调查[M].北京:人民卫生出版社,2010,6.
  • 3Losken A, Jurkiewicz MJ. History of breast reconstruction[J]. Breast Dis, 2002, 16: 3-9.
  • 4Spear SL, Mardini S, Ganz JC. Resource cost comparison of implant-based breast reconstruction versus TRAM flap breast reconstruetion[J]. Plast Reconstr Surg, 2003, 112 ( 1 ): 101-105.
  • 5Blondeel N, Vanderstraeten C-G, Monstrey SJ, et al. The donor site morbidity of free DIEP flaps and free TRAM flaps for breast reconstruction[J]. Br J Plast Surg, 1997, 50(5) : 322-330.
  • 6Cordeiro PG. Breast reconstruction after surgery for breast caneer[J]. N Engt J Med, 2008, 359(15) : 1590-1601.
  • 7Toth BA, Lappert P. Modified skin incisions for masteetomy: the need for plastic surgical input in preoperative planning[J]. Plast Reconstr Surg, 1991, 87(6): 1048-1053.
  • 8Babiera G, Simmons R. Nipple-areolar complex-sparing mastectomy., feasibility, patient selection~ and technique[J].Ann Surg Oncol, 2010, 17(Suppl 3): 245-248.
  • 9King MC, Marks JH, Mandell JB. Breast and ovarian cancerrisks due to inherited mutations in BRCA1 and BRCA2 [J]. Science, 2003, 302(5645): 643-646.
  • 10Meijers-Heijboer H, van Geel B, van Putten WL, et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation[J]. N Engl J Med, 2001, 345(3) : 159-164.

共引文献370

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部